The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory (R/R) mantle cell lymphoma (MCL).
 
Narendranath Epperla
No Relationships to Disclose
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - Celerant; MedImmune
Research Funding - Takeda
 
Kwang Woo Ahn
No Relationships to Disclose
 
Eunhye Oak
No Relationships to Disclose
 
Amanda F. Cashen
Speakers' Bureau - Celgene; Gilead Sciences; Seagen; Spectrum Pharmaceuticals
 
Abraham Sebastian Kanate
No Relationships to Disclose
 
Oscar Calzada
No Relationships to Disclose
 
Zachary Luke Farmer
No Relationships to Disclose
 
Michael Tallarico
No Relationships to Disclose
 
Chadi Nabhan
Consulting or Advisory Role - Cardinal Health; Celgene; Genentech; Medivation
Research Funding - Celgene; Genentech; Medivation
 
Luciano J Costa
Honoraria - Amgen; Sanofi Pasteur
Research Funding - Amgen; GlaxoSmithKline; Karyopharm Therapeutics
 
Vaishalee Padgaonkar Kenkre
No Relationships to Disclose
 
Nilanjan Ghosh
Consulting or Advisory Role - Abbvie; Celgene; Janssen; Seagen
Speakers' Bureau - Celgene; Gilead Sciences; Janssen
Research Funding - Bristol-Myers Squibb; Genentech; Janssen; Millennium; Pharmacyclics; Seagen; TG Therapeutics
 
Jonathon Brett Cohen
No Relationships to Disclose
 
Parameswaran Hari
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Amgen; Celgene; Millennium; Novartis; Sanofi; Spectrum Pharmaceuticals
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Timothy S. Fenske
Consulting or Advisory Role - Celgene; Seagen
Research Funding - Millennium